Publication

Differential prognostic impact of MYC and PCAT-1 copy number alterations and mRNA expression in intermediate risk prostate cancer: Experience from the Canadian Prostate Cancer Gene Consortium cohort

Bellur, S
Weiss, J
Pintilie, M
Frazer, M
Vincent, H
Boutros, P
Bristow, Robert G
Van der Kwast, T
Keywords
Type
Meetings and Proceedings
Citation
Differential prognostic impact of MYC and PCAT-1 copy number alterations and mRNA expression in intermediate risk prostate cancer: Experience from the Canadian Prostate Cancer Gene Consortium cohort. 2018, 31: 327 Mod Pathol
Journal Title
Journal ISSN
Volume Title
Embedded videos